AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 170 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | +100.0% | 102 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 102 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 102 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 102 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 102 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 102 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 102 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -66.7% | 102 | -60.9% | 0.00% | – |
| Q3 2020 | $3,000 | -25.0% | 261 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | 0.0% | 261 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -33.3% | 261 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | 0.0% | 261 | -9.7% | 0.00% | – |
| Q3 2019 | $6,000 | -33.3% | 289 | 0.0% | 0.00% | – |
| Q2 2019 | $9,000 | -35.7% | 289 | 0.0% | 0.00% | – |
| Q1 2019 | $14,000 | +100.0% | 289 | +42.4% | 0.00% | – |
| Q4 2018 | $7,000 | -41.7% | 203 | 0.0% | 0.00% | – |
| Q3 2018 | $12,000 | -14.3% | 203 | 0.0% | 0.00% | – |
| Q2 2018 | $14,000 | +27.3% | 203 | 0.0% | 0.00% | – |
| Q1 2018 | $11,000 | – | 203 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
| Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
| Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
| SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
| DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
| Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
| PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
| HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
| Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |